ClinicalTrials.Veeva

Menu

Nasospore Stent For Use in Enodscopic Sinus Surgery

Lahey Health logo

Lahey Health

Status and phase

Withdrawn
Phase 4

Conditions

Chronic Sinusitis

Treatments

Drug: Nasopore Stent and either Gentamycin or Bacitracin
Drug: Merogel Nasal Stent and Nasopore Stent

Study type

Interventional

Funder types

Other

Identifiers

NCT00671541
LCID 2006-026

Details and patient eligibility

About

The purpose of this study is to evaluate a stenting material called Nasopore. This is a synthetic material approved by FDA for use as a stent in postoperative sinus surgery patients. This study will compare the Nasopore stent to other approved stenting materials.

Full description

This study will compare other sinus stenting products to the Nasopore stent. The stents will be soaked in antibiotic solutions and be observed for how well they perform. Subjects will have a stent placed in each sinus, stents may be the standard antibiotic saturated materials or the new nasopore material or nasopore stent soaked in antibiotics.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Evaluation by Otolaryngologist & determined to need endoscopic sinus surgery
  • Only subjects with Bilateral disease

Exclusion criteria

  • Pediatric subjects(under the age of 18)

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

Merogel stent vs. Nasopore Stent
Active Comparator group
Description:
This study has two arms consiting of 50 subjects each (100 total) Arm 1 will recieve the standard stent (merogel)in their right sinus and a nasopore stent in their left sinus.
Treatment:
Drug: Merogel Nasal Stent and Nasopore Stent
bacitracin vs. gentamicin treated stent
Experimental group
Description:
The second arm will consist of 50 new subjects. These 50 subjects will have a nasopore stent placed in the left sinus. The first 25 subjects will have nasopore stent placed postoperatively with a bacitracin soaked nasopore in right sinus the second 25 will have a gentamycin soaked nasopore stent in right sinus.
Treatment:
Drug: Merogel Nasal Stent and Nasopore Stent
Drug: Nasopore Stent and either Gentamycin or Bacitracin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems